Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-014926
Filing Date
2013-03-07
Accepted
2013-03-07 16:18:52
Documents
1
Period of Report
2013-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3235
  Complete submission text file 0001209191-13-014926.txt   4755
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Issuer) CIK: 0001145404 (see all company filings)

EIN.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O COLLAGENEX PHARMACEUTICALS, INC. 41 UNIVERSITY DRIVE NEWTOWN PA 18940
Business Address
Powell Andrew Kenneth William (Reporting) CIK: 0001304113 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50767 | Film No.: 13673676